Early Hormone Therapy May Protect Brain Function in Postmenopausal Women
Mayo Clinic study reveals how early estrogen treatment affects brain blood flow and cognitive aging in postmenopausal women.
20 articles
Mayo Clinic study reveals how early estrogen treatment affects brain blood flow and cognitive aging in postmenopausal women.
Brain scans reveal how testosterone suppression in prostate cancer treatment could lead to cognitive decline in aging men.
Eight-week mindfulness program tested for women experiencing severe menopause symptoms after preventive ovary removal surgery.
TONTT2 tests whether erythropoietin dose and timing can be optimized to best preserve vision after traumatic optic neuropathy.
Personalized treatment approach targeting multiple causes of cognitive decline outperformed standard care in 9-month trial.
A completed Mount Sinai RCT tested whether HBOT can improve brain blood flow and cognition in diabetic elders with mild cognitive impairment.
A first-in-human multiple-ascending-dose trial tests Contraloid, an oral peptide designed to disassemble toxic amyloid-beta oligomers linked to Alzheimer's disease.
A pilot RCT tested whether a smartphone app could improve quality of life and treatment adherence in HIV-positive patients aged 60+.
Age-tailored cognitive behavioral intervention tested in 20 older women with binge eating disorder in pilot study.
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.
12-week study reveals how aerobic and strength training improve cognitive performance by altering stress hormones and brain proteins.
NGP 555 targets toxic brain protein production in healthy volunteers, offering potential early intervention for Alzheimer's prevention.
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
A completed Phase 4 trial from India evaluates whether ALA supplementation boosts flunarizine's migraine-prevention power in adolescents.
The EPICURO trial tests MERIVAยฎ turmeric over 6 months to see if it protects cognition in adults with metabolic syndrome.
Contraloid acetate, an oral all-D-peptide designed to disassemble toxic amyloid-beta oligomers, completed its first-in-human safety trial in 40 healthy volunteers.
Pilot study tests psilocybin-assisted psychotherapy to help hospice patients overcome demoralization and existential suffering.
32-person study explores how intermittent fasting affects blood vessel function and brain performance through protective pathways.
Small trial tests psychedelic therapy combined with meditation for frontline healthcare providers suffering COVID-related burnout.